CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Net Cash Provided by (Used in) Discontinued Operations
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) reported Net Cash Provided by (Used in) Discontinued Operations of -$1.08 million for the 12-month period ending 2014-12-27, per its 10-K filed 2015-02-17.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:NetCashProvidedByUsedInDiscontinuedOperations · last filed 2015-02-17
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. net cash provided by (used in) discontinued operations for the quarter ending 2014-12-27 was -$511.00K.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. net cash provided by (used in) discontinued operations for the quarter ending 2014-09-27 was $119.00K.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. net cash provided by (used in) discontinued operations for the quarter ending 2014-06-28 was -$25.00K.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. net cash provided by (used in) discontinued operations for the quarter ending 2014-03-29 was -$664.00K.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. net cash provided by (used in) discontinued operations for fiscal 2014 was -$1.08M.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. net cash provided by (used in) discontinued operations for fiscal 2013 was -$1.91M.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. net cash provided by (used in) discontinued operations for fiscal 2012 was -$106.00K.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. net cash provided by (used in) discontinued operations for fiscal 2011 was -$1.56M, a 143.50% decline from fiscal 2010.
| Period end | Net Cash Provided by (Used in) Discontinued Operations 3 month | Net Cash Provided by (Used in) Discontinued Operations 6 month | Net Cash Provided by (Used in) Discontinued Operations 9 month | Net Cash Provided by (Used in) Discontinued Operations 12 month | Net Cash Provided by (Used in) Discontinued Operations 12 month as first filed |
|---|---|---|---|---|---|
| 2014-12-27 | -$511.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-17 | -$392.00K derived: sum of 2 quarters · filed 2015-02-17 | -$417.00K derived: sum of 3 quarters · filed 2015-02-17 | -$1.08M 10-K · filed 2015-02-17 | |
| 2014-09-27 | $119.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-30 | $94.00K derived: sum of 2 quarters · filed 2014-10-30 | -$570.00K 10-Q · filed 2014-10-30 | -$943.00K derived: sum of 4 quarters · filed 2015-02-17 | |
| 2014-06-28 | -$25.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | -$689.00K 10-Q · filed 2014-08-07 | -$1.06M derived: sum of 3 quarters · filed 2015-02-17 | -$1.65M derived: sum of 4 quarters · filed 2015-02-17 | |
| 2014-03-29 | -$664.00K 10-Q · filed 2014-04-30 | -$1.04M derived: sum of 2 quarters · filed 2015-02-17 | -$1.62M derived: sum of 3 quarters · filed 2015-02-17 | -$2.57M derived: sum of 4 quarters · filed 2015-02-17 | |
| 2013-12-28 | -$373.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-17 | -$960.00K derived: sum of 2 quarters · filed 2015-02-17 | -$1.90M derived: sum of 3 quarters · filed 2015-02-17 | -$1.91M 10-K · filed 2015-02-17 | |
| 2013-09-28 | -$587.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-30 | -$1.53M derived: sum of 2 quarters · filed 2014-10-30 | -$1.53M 10-Q · filed 2014-10-30 | -$1.35M derived: sum of 4 quarters · filed 2015-02-17 | |
| 2013-06-29 | -$943.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | -$946.00K 10-Q · filed 2014-08-07 | -$760.00K derived: sum of 3 quarters · filed 2015-02-17 | -$964.00K derived: sum of 4 quarters · filed 2015-02-17 | |
| 2013-03-30 | -$3.00K 10-Q · filed 2014-04-30 | $183.00K derived: sum of 2 quarters · filed 2015-02-17 | -$21.00K derived: sum of 3 quarters · filed 2015-02-17 | -$109.00K derived: sum of 4 quarters · filed 2015-02-17 | |
| 2012-12-29 | $186.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-17 | -$18.00K derived: sum of 2 quarters · filed 2015-02-17 | -$106.00K derived: sum of 3 quarters · filed 2015-02-17 | -$106.00K 10-K · filed 2015-02-17 | |
| 2012-09-29 | -$204.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-30 | -$292.00K derived: sum of 2 quarters · filed 2013-10-30 | -$292.00K 10-Q · filed 2013-10-30 | -$148.00K derived: sum of 4 quarters · filed 2014-02-25 | |
| 2012-06-30 | -$88.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-07-31 | -$88.00K 10-Q · filed 2013-07-31 | $56.00K derived: sum of 3 quarters · filed 2014-02-25 | $101.00K derived: sum of 4 quarters · filed 2014-02-25 | |
| 2012-03-31 | $0.00 10-Q · filed 2013-05-08 | $144.00K derived: sum of 2 quarters · filed 2014-02-25 | $189.00K derived: sum of 3 quarters · filed 2014-02-25 | -$1.73M derived: sum of 4 quarters · filed 2014-02-25 | |
| 2011-12-31 | $144.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-25 | $189.00K derived: sum of 2 quarters · filed 2014-02-25 | -$1.73M derived: sum of 3 quarters · filed 2014-02-25 | -$1.56M 10-K · filed 2014-02-25 | |
| 2011-09-24 | $45.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-01 | -$1.88M derived: sum of 2 quarters · filed 2012-11-01 | -$1.70M 10-Q · filed 2012-11-01 | -$1.57M derived: sum of 4 quarters · filed 2013-02-27 | |
| 2011-06-25 | -$1.92M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-07 | -$1.75M 10-Q · filed 2012-08-07 | -$1.62M derived: sum of 3 quarters · filed 2013-02-27 | -$812.00K derived: sum of 4 quarters · filed 2013-02-27 | |
| 2011-03-26 | $175.00K 10-Q · filed 2012-05-04 | $307.00K derived: sum of 2 quarters · filed 2013-02-27 | $1.11M derived: sum of 3 quarters · filed 2013-02-27 | $1.39M derived: sum of 4 quarters · filed 2013-02-27 | |
| 2010-12-25 | $132.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-27 | $936.00K derived: sum of 2 quarters · filed 2013-02-27 | $1.21M derived: sum of 3 quarters · filed 2013-02-27 | $3.58M 10-K · filed 2013-02-27 | $3.65M 10-K · filed 2011-02-23 |
| 2010-09-25 | $804.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-02 | $1.08M derived: sum of 2 quarters · filed 2011-11-02 | $3.45M 10-Q · filed 2011-11-02 | $5.58M derived: sum of 4 quarters · filed 2012-02-27 | |
| 2010-06-26 | $278.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2011-08-03 | $2.65M 10-Q · filed 2011-08-03 | $4.77M derived: sum of 3 quarters · filed 2012-02-27 | ||
| 2010-03-27 | $2.37M 10-Q · filed 2011-05-04 | $4.49M derived: sum of 2 quarters · filed 2012-02-27 | |||
| 2009-12-26 | $2.12M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-27 | $9.73M 10-K · filed 2012-02-27 | $9.77M 10-K · filed 2011-02-23 | ||
| 2009-09-26 | $7.61M 10-Q · filed 2010-11-04 | ||||
| 2008-12-27 | $6.29M 10-K · filed 2011-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |